It is a healthcare foreign private limited company based in Mumbai, Maharashtra, India, established in 2022.
2022 | Mumbai, Maharashtra, India | ActiveSedia Biosciences (India) Private Limited, a active foreign private limited company, was established on 23 November 2022 in Mumbai, Maharashtra, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U33111MH2022FTC394041. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.50 M.
It upholds a compliant status. Employing 2 professional, Its leadership includes Ronald William Mink (Whole-Time Director), Roger Ian Gale (Whole-Time Director), Sujata Mital Rajindar (Director). Its latest AGM occurred on 23 September 2024, with the balance sheet filed on 31 March 2024. It is based at D1 Krishna Complex, Subhash Road, Vile Parle East, Mumbai, Maharashtra, 400057.
U33111MH2022FTC394041
394041
23 November 2022
₹1.00 Cr
₹1.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Sedia Biosciences (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ronald William Mink | Whole-Time Director | 23 Nov 2022 | Current |
| Roger Ian Gale | Whole-Time Director | 23 Nov 2022 | Current |
| Sujata Mital Rajindar | Director | 23 Nov 2022 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sedia Biosciences (India) Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Sedia Biosciences (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sedia Biosciences (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sedia Biosciences (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sedia Biosciences (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sedia Biosciences (India) Private Limited last Annual general meeting of members was held on 23 Sep 2024 as per latest MCA records. was completed.
Progress on Sedia Biosciences (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The activity Ronald William Mink was appointed as a Whole-time director was appointed as a Whole-time director on 23 Nov 2022 & has been associated with this company since 3 years 4 days . was completed.
The activity Roger Ian Gale was appointed as a Whole-time director was appointed as a Whole-time director on 23 Nov 2022 & has been associated with this company since 3 years 4 days . was completed.
Progress on Sujata Mital Rajindar was appointed as a Director was appointed as a Director on 23 Nov 2022 & has been associated with this company since 3 years 4 days . was documented.
Sedia Biosciences (India) Private Limited was registered on 23 Nov 2022 with Roc Mumbai & aged 3 years 4 days as per MCA records. was recorded as a recent event.
The CIN of Sedia Biosciences (India) Private Limited is U33111MH2022FTC394041.
Sedia Biosciences (India) Private Limited is headquartered at D1 Krishna Complex, Subhash Road, Vile Parle East, Mumbai, Maharashtra, 400057.
Sedia Biosciences (India) Private Limited was incorporated on 23 November 2022.
The current directors of Sedia Biosciences (India) Private Limited are
The primary industry of Sedia Biosciences (India) Private Limited is Trade.
Sedia Biosciences (India) Private Limited is unlisted.
The authorized capital of Sedia Biosciences (India) Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.50 M.
The compliance status of Sedia Biosciences (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX